Hunan Er Kang Pharmaceutical (300267) — Financial Flexibility Index
Hunan Er Kang Pharmaceutical (300267) has a Financial Flexibility Index of 0.45x as of June 2023. Free cash flow of CN¥220.23 Million (operating CF CN¥174.55 Million minus capex CN¥45.68 Million) represents 0% of total liabilities (CN¥490.30 Million). Check Hunan Er Kang Pharmaceutical PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hunan Er Kang Pharmaceutical Financial Flexibility Index (2008–2024)
Historical Financial Flexibility Index trend for Hunan Er Kang Pharmaceutical across 17 annual periods. See 300267 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Hunan Er Kang Pharmaceutical (2008–2024)
Year-by-year free cash flow to debt coverage for Hunan Er Kang Pharmaceutical. For the full company profile including market capitalisation, see 300267 market cap.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.45x | CN¥362.29 Million | CN¥166.69 Million | CN¥797.54 Million | ▼ -21.4% |
| 2023 | 0.58x | CN¥386.61 Million | CN¥148.42 Million | CN¥669.05 Million | ▲ +2.3% |
| 2022 | 0.56x | CN¥454.51 Million | CN¥281.02 Million | CN¥804.57 Million | ▼ -28.7% |
| 2021 | 0.79x | CN¥442.02 Million | CN¥92.68 Million | CN¥558.28 Million | ▼ -24.0% |
| 2020 | 1.04x | CN¥784.42 Million | CN¥178.53 Million | CN¥753.22 Million | ▼ -54.9% |
| 2019 | 2.31x | CN¥810.03 Million | CN¥445.82 Million | CN¥350.72 Million | ▲ +328.6% |
| 2018 | 0.54x | CN¥220.62 Million | CN¥123.89 Million | CN¥409.39 Million | ▼ -82.5% |
| 2017 | 3.07x | CN¥948.03 Million | CN¥689.11 Million | CN¥308.37 Million | ▼ -23.0% |
| 2016 | 3.99x | CN¥1.63 Billion | CN¥486.50 Million | CN¥408.94 Million | ▲ +99.3% |
| 2015 | 2.00x | CN¥1.09 Billion | CN¥518.96 Million | CN¥544.10 Million | ▲ +54.6% |
| 2014 | 1.30x | CN¥702.81 Million | CN¥175.38 Million | CN¥542.64 Million | ▼ -61.3% |
| 2013 | 3.35x | CN¥378.20 Million | CN¥174.22 Million | CN¥113.01 Million | ▼ -22.2% |
| 2012 | 4.30x | CN¥315.31 Million | CN¥84.02 Million | CN¥73.32 Million | ▲ +137.0% |
| 2011 | 1.81x | CN¥119.59 Million | CN¥75.72 Million | CN¥65.90 Million | ▲ +101.1% |
| 2010 | 0.90x | CN¥107.52 Million | CN¥42.47 Million | CN¥119.15 Million | ▲ +129.2% |
| 2009 | 0.39x | CN¥29.82 Million | CN¥10.18 Million | CN¥75.72 Million | ▲ +82.2% |
| 2008 | 0.22x | CN¥12.83 Million | CN¥211.00K | CN¥59.37 Million | — |